Improvements in immunosuppressive therapy have resulted in longer survival of kidney transplants, but they also may increase the incidence of post-transplant malignancies.
A German study of 1,882 kidney transplant patients published recently in Clinical Transplantation (2013;27:E30-E36) found a 12-fold higher risk of developing a post-transplant non-skin cancer compared with the age-matched general population.
The most common malignancies were those of the urinary tract. The authors concluded that close tumor screening after kidney transplantation is warranted. Renal & Urology News would like to know what nephrologists think about this, so please answer the following online poll question.